Prognostic effects of calcium channel blockers in patients with vasospastic angina: A meta-analysis

Circulation Journal

Volumn 74, Issue 9, 2010, Pages 1943-1950

  Nishigaki, Kazuhiko ^a   Inoue, Yukiko ^b   Yamanouchi, Yoshio ^b   Fukumoto, Yoshihiro ^c   Yasuda, Satoshi ^c   Sueda, Shozo ^d   Urata, Hidenori ^b   Shimokawa, Hiroaki ^c   Minatoguchi, Shinya ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Fukuoka University Chikushi Hospital   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Ehime Prefectural Niihama Hospital   (Japan)

Author keywords

Calcium channel blockers; Prognosis; Vasospastic angina

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BENIDIPINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; NICORANDIL; NIFEDIPINE;

ACUTE HEART INFARCTION; AGE; ANGINA PECTORIS; AORTA ANEURYSM; ARTICLE; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; DIABETES MELLITUS; EVENT FREE SURVIVAL; HAZARD RATIO; HEART DEATH; HEART FAILURE; HUMAN; JAPANESE; PROGNOSIS;

AMLODIPINE; ANGINA PECTORIS; ASIAN CONTINENTAL ANCESTRY GROUP; CALCIUM CHANNEL BLOCKERS; CORONARY VASOSPASM; DIHYDROPYRIDINES; DILTIAZEM; HUMANS; NIFEDIPINE; PROGNOSIS; TREATMENT OUTCOME;

EID: 77956107356     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0292     Document Type: Article

References (29)

1. Shimokawa H, Nagasawa K, Irie T, Egashira S, Egashira K, Sagara T, et al. Clinical characteristics and long-term prognosis of patients with variant angina: A comparative study between western and Japanese populations. Int J Cardiol 1988; 18: 331-349.
2. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: Differences between Japanese and Caucasian patients. J Am Coll Cardiol 1999; 33: 1442-1452.
3. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 2000; 101: 1102-1108.
4. Morikami Y, Yasue H. Efficacy of slow-release nifedipine on myocardial ischemic episodes in variant angina pectoris. Am J Cardiol 1991; 68: 580-584.
5. Yasue H, Morikami Y. Efficacy of slow-release nifedipine on ischemic attacks in patients with variant angina. Cardiovascular Drugs & Therapy 1990; 4: 915-918.
6. Kimura E, Kishida H. Treatment of variant angina with drugs: A survey of 11 cardiology institutes in Japan. Circulation 1981; 63: 844-848.
7. Maseri A, Beltrame JF, Shimokawa H. Role of coronary vasoconstriction in ischemic heart disease and search for novel therapeutic targets. Circ J 2009; 73: 394-403.
8. Nakamura Y, Sasayama S, Nonogi H, Miyazaki S, Fujita M, Kihara Y, et al. Effects of pacing-induced ischemia on early left ventricular filling and regional myocardial dynamics and their modification by nifedipine. Circulation 1987; 76: 1232-1244.
9. Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, et al. Long-term prognosis for patients with variant angina and influential factors. Circulation 1988; 78: 1-9.
10. Ito A, Fukumoto Y, Shimokawa H. Changing characteristics of patients with vasospastic angina in the era of new calcium channel blockers. J Cardiovasc Pharmacol 2004; 44: 480-485.
11. Io K, Minatoguchi S, Nishigaki K, Ojio S, Tanaka T, Segawa T, et al. Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina: Cohort study with evaluation of the ergonovine coronary spasm induction test. Arzneimittel-forschung/Drug Res 2007; 57: 573-581.
12. Sueda S, Oshita A, Izoe Y, Kohno H, Fukuda H. Investigation of the influential factor in prognosis and the result of medical therapy in patients with coronary spastic angina. Kokyu To Junkan 2006; 54: 1255-1261 (in Japanese).
13. Kodama S, Inoue Y, Mihara H, Sumi S, Kudo K, Okamura K, et al. Influential factors for long-term prognosis in patients with vasospastic angina. Kokyu To Junkan 2007; 55: 1157-1164 (in Japanese).
14. Fukumoto Y, Yasuda S, Ito A, Shimokawa H. Prognostic effects of benidipine in patients with vasospastic angina: Comparison with diltiazem and amlodipine. J Cardiovasc Pharmacol 2008; 51: 253-257.
15. The Japanese Circulation Society. Guidelines for Diagnosis and Treatment of Patients with Coronary Spastic Angina (JCS 2008). Circ J 2008; 72(Suppl IV): 1195-1238 (in Japanese).
16. Shinozaki K, Suzuki M, Ikebuchi M, Takaki H, Hara Y, Tsushima M, et al. Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina. Circulation 1995; 92: 1749-1757.
17. Healthy bureau, The Ministry of Health, Labour and Welfare. Diabetic investigation of acual conditions report in 2002 fiscal year: Tokyo. Tokyo: The Ministry of Health, Labour and Welfare; 2004.
18. Yamagishi M, Ito K, Tsutsui H, Miyazaki S, Goto Y, Nagaya N, et al. Lesion severity and hypercholesterolemia determine long-term prognosis of vasospastic angina treated with calcium channel antagonists. Circ J 2003; 67: 1029-1035.
19. Yasue H, Omote S, Takizawa A, Nagao M. Coronary arterial spasm in ischemic heart disease and its pathogenesis: A review. Circ Res 1983; 52: 1147-1152.
20. Karasawa A, Kubo K. Calcium antagonistic effects and the in vitro duration of actions of KW-3049, a new 1,4-dihydropyridine derivative, in isolated canine coronary arteries. Jpn J Pharmacol 1988; 47: 35-44.
21. Moriyama T, Karasawa A. Cardiovascular effects of benidipine and amlodipine in isolated tissues and anesthetized dogs. Biol Pharm Bull 1994; 17: 1468-1471.
22. Karasawa A, Kubo K, Shuto K, Oka T, Nakamizo N. Pharmacological actions of benidipine hydrochloride in several isolated smooth muscles and myocardium. Arzneimittel-forschung/Drug Res 1988; 38: 1722-1730.
23. Shimada S, Nakajima Y, Yamamoto K, Sawada Y, Iga T. Comparative pharmacodynamics of eight calcium channel blocking agents in Japanese essential hypertensive patients. Biol Pharm Bull 1996; 19: 430-437.
24. Miwa Y, Masai H, Shimizu M. Differential effects of calciumchannel blockers on vascular endothelial function in patients with coronary spastic angina. Circ J 2009; 73: 713-717.
25. Makino H, Aoki M, Hashiya N, Yamasaki K, Shimizu H, Miwa K, et al. A calcium- channel blocker, benidipine, improves forearm reactive hyperemia in patients with essential hypertension. Blood Press Suppl 2005; 1: 39-44.
26. Kita T, Suzuki Y, Eto T, Kitamura K. Long-term anti-hypertensive therapy with benidipine improves arterial stiffness over blood pressure lowering. Hypertens Res 2005; 28: 959-964.
27. Takenaka T, Takane H, Okada H, Ohno Y, Suzuki H. Long-term effects of calcium antagonists on augmentation index in hypertensive patients with chronic kidney disease. NDS Plus 2009; 2: 192-193.
28. Wang N, Minatoguchi S, Chen XH, Arai M, Uno Y, Lu C, et al. Benidipine reduces myocardial infarct size involving reduction of hydroxyl radicals and production of protein kinase C-dependent nitric oxide in rabbits. J Cardiovasc Pharmacol 2004; 43: 747-757.
29. Suzuki H, Yokoyama K, Akimoto Y, Daida H. Clinical efficacy of benidipine for vasospastic angina pectoris. Arzneimittel-forschung/ Drug Res 2007; 57: 20-25.